Browse by lab.

1 panel

OmegaQuant

OmegaQuant: Pioneering the Way in Omega-3 and Nutritional Biomarker Testing OmegaQuant is a leading laboratory specializing in omega-3 fatty acid and nutritional biomarker testing. Founded by Dr. William Harris, a renowned researcher in the field of omega-3 fatty acids, OmegaQuant has revolutionized the way individuals, healthcare professionals, and researchers can monitor essential fatty acids like EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in the body. With a commitment to providing accurate, accessible, and evidence-based insights, OmegaQuant plays a critical role in helping people optimize their health through targeted dietary adjustments. What is OmegaQuant? Founded in 2009, OmegaQuant was created to address a growing need for reliable and easy-to-access omega-3 testing. As more research illuminated the profound health benefits of omega-3 fatty acids—particularly their role in heart, brain, and inflammatory health—the demand for precise, clinical-grade testing increased. Dr.

View laboratory

Oswaldo Cruz Laboratório

Oswaldo Cruz Laboratório is a leading biomedical research and diagnostic institution in Brazil, renowned for its contributions to public health and disease prevention. Named after the famous Brazilian scientist Oswaldo Cruz, the laboratory specializes in advanced diagnostic testing for infectious diseases, genetic research, and immunological studies. With a strong commitment to innovation and collaboration, Oswaldo Cruz Laboratório partners with national and international health organizations to improve healthcare outcomes. Known for its high standards of accuracy and reliability, the laboratory plays a vital role in combating diseases and advancing medical science. As a trusted name in diagnostics, Oswaldo Cruz Laboratório is dedicated to enhancing public health through cutting-edge technology and expertise.

View laboratory

Oxford Biomedical Technologies

Oxford Biomedical Technologies is renowned for its pioneering work in the field of diet-induced inflammation, therapy, training, and technology development. Central to their work is the patented Mediator Release Test (MRT®) and the proprietary LEAP (Lifestyle Eating And Performance) anti-inflammatory eating plans. The company's expertise is backed by a strong record of innovation, having authored several U.S. and international patents related to diet-induced inflammation technology. The Mediator Release Test (MRT®) is a key offering from Oxford Biomedical Technologies. This test quantifies the inflammatory response to foods and food chemicals, helping in the diagnosis and management of various conditions like IBS, migraines, and fibromyalgia that are affected by diet-induced inflammation. MRT® operates on the principle that the release of mediators like cytokines and histamine from white blood cells is the primary cause of negative effects in food-sensitivity sufferers.

View laboratory